Research & Development Solutions
Research & Development Solutions
Clinical trial recruitment and site selection can be difficult, especially
in rare diseases.
Trio's strong relationships with large networks of community practices, innovative technology platforms, and comprehensive, real-time patient insights make it quick and easy to identify
patients who meet your criteria and demographic representation.
A Deep Dive into Clinical Realities
SPECTRA offers comprehensive chart reviews that transform unstructured data from patient records into actionable insights. By extracting detailed information from physician notes, lab results, and other sources, SPECTRA provides a deeper understanding of treatment outcomes, adherence patterns, and patient journeys.
Streamline Trial Recruitment Efforts
CONVERGE streamlines the patient and site identification process helping our clients find representative and understudied populations, for clinical trial recruitment needs. This hands-on support leverages comprehensive analysis to rapidly identify patients and sites, ensuring trials progress efficiently and effectively.
Empower Your Strategic Initiatives
TRIO360 offers custom research and analytics support through our managed services that leverage Trio Health’s agile data capabilities providing our clients with deep, actionable insights. From data visualization to complex analytics projects, TRIO360 is collaborative and flexible to meet your business objectives.
Unmet need identification to inform research decisions
Optimize patient identification & feasibility for clinical trials
Ensure trial diversity and representation, innovate and improve trial design
Our Competitive Advantage
- Ability to monitor real-world drug usage and safety in real-time
- Linking data via Datavant Tokens to supplement data and insights
- Direct EMR access to identify unmet patient needs at the physician/practice level
- Access to the physician and patient voice to understand the why behind treatment decisions
- Scientific Steering Committees (SSCs) comprised of highly respected, disease-specific key opinion
leaders (KOLs) to identify key research trends to support innovative study designs